Nkarta Inc. (NKTX) Social Stream



Nkarta Inc. (NKTX): $3.55

0.15 (+4.41%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NKTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 379

in industry

NKARTA INC (NKTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering NKARTA INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-10 4 $77 $71 $74.333 $3.37 2105.73%
2021-11-16 4 $75 $71 $72.333 $3.37 2046.38%
2021-11-18 5 $75 $50 $66.75 $3.37 1880.71%
2022-03-18 7 $75 $25 $58.4 $3.37 1632.94%
2022-03-29 8 $71 $17 $43 $3.37 1175.96%
2022-04-01 8 $71.001 $17 $43 $3.37 1175.96%
2022-05-13 8 $60 $32 $44.333 $3.37 1215.52%
2022-07-18 9 $60 $30 $42.285 $3.37 1154.75%
2022-08-12 9 $50 $26 $37.428 $3.37 1010.62%
2022-10-14 11 $50 $25 $35.875 $3.37 964.54%
2022-11-10 12 $50 $25 $33.875 $3.37 905.19%
2022-11-16 11 $38 $25 $30.875 $3.37 816.17%
2022-12-05 11 $38 $25 $30.555 $3.37 806.68%
2023-03-16 10 $38 $25 $30.142 $3.37 794.42%
2023-03-17 10 $32 $21 $27.142 $3.37 705.4%

The Trend in the Analyst Price Target


Over the past 52 weeks, NKTX's average price target has gone down $31.26.

NKTX reports an average of 216.71% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-07-28 10 60 26 40.250 13.32 202.18%
2022-08-12 9 50 26 37.428 17.37 115.47%
2022-10-10 11 50 25 35.875 13.52 165.35%
2022-11-16 10 38 25 30.142 9.82 206.95%
2022-11-16 11 38 25 30.875 9.82 214.41%

NKTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 7 2 1 0 0 10

The Trend in the Broker Recommendations


NKTX's average broker recommendation rating improved by 0.35 over the prior 23 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, NKARTA INC's upside potential (average analyst target price relative to current price) is higher than 2893.41% of them.
  • NKARTA INC's number of analysts covering the stock is greater than 1904.42% of stocks in the mid market cap category.
  • NKARTA INC's variance in analysts' estimates is lower than -1778.46% of stocks in the mid market cap category.
  • NKTX has a greater average analyst price target than 1902.73% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, ALXO, HRMY, and PRLD are the three stocks most similar to NKARTA INC regarding the price target and analyst recommendation information presented here.

Is NKTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7487 seconds.